Replies to post #104920 on Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Look, my personal opinion that the recent HOT data is supported by the reaction from the Wall Street bankers -- a big yawn.
I'm not Zach Hartman (remember him?) and will not digest you the data from the recent trials. Instead, I do tend to compare the data released from different companies re: the same indication/patient condition. If you compare the data that way, you can see that the ADXS/HOT data is not overwhelming. Nobody was blown out of water, and no earth shattering results published. There was some response to the treatment, but the data is not that makes the heads turn. No yet. Will the data get better as it matures? Remains to be seen.
PS. The next raise is coming. Soon, by the end of this summer. You'll see another pathetic attempt to pump before the secondary. When you see a batch of fluff PRs, run for the covers!